(f) See Item 2(a)-(b) above for citizenship or place of organization, as applicable, of each of the Reporting Persons.
The Reporting Persons have entered into an agreement of joint filing, a copy of which is attached hereto as Exhibit 1.
Item 3. | Source and Amount of Funds or Other Consideration |
Prior to the Issuer’s initial public offering in 2021 (the “IPO”), the Riverwood-Managed Entities purchased an aggregate of 13,355,046 shares of Class B Common Stock for an aggregate purchase price of $3,489,088
Since the IPO, the Riverwood-Managed Entities have purchased an aggregate of 1,639,875 shares of Class A Common Stock in the open market at various prices for an aggregate purchase price of approximately $5,811,603 and converted an aggregate of 2,100,000 shares of Class B Common Stock into 2,100,000 shares of Class A Common Stock.
The source of funds used for the purchases described herein were from general funds available to the Riverwood-Managed Entities, including capital contributions from their respective investors.
Item 4. | Purpose of Transaction |
The information provided or incorporated by reference in Items 3 and 6 are hereby incorporated by reference herein.
All of the securities reported herein were acquired for investment purposes. The Reporting Persons intend to review on a continuing basis their investment in the Issuer. Based on such review, market conditions and other factors (including evaluation of the Issuer’s businesses and prospects, availability of funds, alternative uses of funds and general economic conditions), the Reporting Persons may, from time to time, acquire additional securities of the Issuer or dispose of all or a portion of their investment in the Issuer or formulate other purposes, plans or proposals regarding the Issuer or any of its securities, to the extent deemed advisable in light of the Issuer’s business, financial condition and operating results, general market and industry conditions or other factors.
On August 31, 2022, the Riverwood-Managed Entities entered into a Rule 10b5-1 purchase plan (the “2022 Rule 10b5-1 Plan”) pursuant to which, over a period starting on October 3, 2022 and ending on February 15, 2023, or an earlier date at which all shares under the 2022 Rule 10b5-1 Plan have been purchased, the Riverwood-Managed Entities may purchase up to an aggregate of $10,000,000 of shares of the Issuer’s Class A Common Stock, subject to certain pricing limits. The amount and timing of any purchases, if any, may vary and will be determined based on market conditions, share price and other factors. The program will not require the Riverwood-Managed Entities to purchase any specific number of shares of Class A Common Stock or at all, and may be modified, suspended or terminated at any time without notice. As the date hereof, pursuant to the 2022 Rule 10b5-1 Plan, the Riverwood-Managed Entities have purchased an aggregate of 1,639,875 shares of Class A Common Stock in the open market at various prices for an aggregate purchase price of approximately $5,811,603.
On December 13, 2022, each of the Riverwood-Managed Entities entered into a Rule 10b5-1 purchase plan (the “2023 Rule 10b5-1 Plan”) pursuant to which, over a period starting February 16, 2023 and ending on April 14, 2023, or an earlier date at which all shares of Class A Common Stock under the 2023 Rule 10b5-1 Plan have been purchased, the Riverwood-Managed Entity may purchase up to an aggregate of $10,000,000, less the dollar amount of shares purchased pursuant to the 2022 Rule 10b5-1 Plan, of shares of Class A Common Stock subject to certain pricing limits. The amount and timing of any purchases, if any, may vary and will be determined based on market conditions, share price and other factors. The program will not require the Riverwood-Managed Entities to purchase any specific number of shares of Class A Common Stock or at all, and may be modified, suspended or terminated at any time without notice.
Currently, Francisco Alvarez-Demalde, co-founder and managing partner of Riverwood Capital, serves on the Board of Directors of the Issuer and, in such capacity, may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.
In their capacity as significant stockholders of the Issuer, the Reporting Persons may take an active role in working with the Issuer’s management and the board of directors on operational, financial and strategic initiatives and may engage in communications with one or more other stockholders or other securityholders of the Issuer as well. Each of the Reporting Persons, in its capacity as a shareholder of the Issuer, may discuss ideas that, if effected, may relate to or result in any of the matters listed in Items 4(a)-(j) of Schedule 13D.
13